The European Investment Bank is lending €20 million to BioLamina, the Swedish biotech that supplies the laminin-based cell culture matrices used by stem cell therapy developers worldwide. The funding will support expanded production of laminin technologies and animal-free drug safety testing methods. BioLamina, the Stockholm-based biotechnology company that produces the protein scaffolding used to grow […]<br /> This story continues at The Next Web [...]
Theom, the company redefining data governance and security for the AI era, announced today it has raised $20 million in Series A funding to accelerate its mission of securing sensitive enterprise data [...]
We aren't even two weeks into the new year and Ubisoft is already looking to carry out its second round of layoffs in 2026. The company has informed workers at Massive Entertainment and Ubisoft S [...]
Ubisoft still isn’t giving us a new Splinter Cell game, but Sam Fisher fans are at least getting an animated TV adaptation very soon. At this week’s Anime NYC convention, Netflix revealed a new te [...]
Australian-German startup Quantum Brilliance has raised $20mn in Series A funding as it looks to deploy small, portable quantum accelerators that promise to supercharge the computational power of ever [...]